Biosimilars are making an impact in the GI field. Dr. Jennifer Caudle and Dr. Stephen Hanauer discuss the evolving role of biosimilars in anti-inflammatory care for GI patients.
Trending
- GLP-1s linked to better IBD outcomes, hinting at role as ‘valuable adjunctive therapies’ (Healio)
- The cyber siege of private practices: Are you at risk? (Medical Economics)
- Is The Galleri Cancer Test Worth It? A Doctor Explains (Forbes)
- With a little help from my friends: What gastrointestinal pathologists need to know from gastroenterologists (GI & Hepatology News)
- The GI innovations transforming outcomes (Becker’s GI & Endoscopy)
- The Smart Toilet: Turning Waste Into Health Insights – Dr. Sonia Grego, Ph.D. (Progress, Potential, and Possibilities | YouTube)
- Peripheral gaze guidance improves adenoma detection rate (GI & Hepatology News)
- Artificial Intelligence for Gastroenterology Practice: A Modified Delphi Consensus (American Journal of Gastroenterology)
